Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Sep;58(9):765–771. doi: 10.1136/thorax.58.9.765

Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats

W Dik 1, R McAnulty 1, M Versnel 1, B Naber 1, L Zimmermann 1, G Laurent 1, S Mutsaers 1
PMCID: PMC1746812  PMID: 12947134

Abstract

Background: Corticosteroids are routinely used in patients with pulmonary fibrosis. The timing for initiation of treatment is likely to be crucial for corticosteroids to exert an antifibrotic effect. Experimental studies in animals have examined the effect of corticosteroid treatment starting before or at the time of lung injury. However, this is not representative of the human condition as treatment only begins after disease has been established. We examined the effect of a short course corticosteroid treatment starting 3 days after bleomycin induced lung injury on the development of pulmonary fibrosis.

Methods: Bleomycin (1.5 mg/kg) was instilled intratracheally into rats to induce pulmonary fibrosis. The effect of a 3-day course of dexamethasone (0.5 mg/kg) initiated 3 days after bleomycin induced lung injury on cell proliferation and collagen deposition was examined by analysing bronchoalveolar lavage (BAL) fluid and lung tissue.

Results: Treating bleomycin exposed animals after injury with dexamethasone for 3 days inhibited lung collagen deposition compared with animals exposed to bleomycin without dexamethasone treatment (15.2 (2.2) mg collagen/lung v 22.5 (2.1) mg/lung; p<0.05). Dexamethasone treatment reduced pulmonary parenchymal cell proliferation in bleomycin exposed rats but did not influence BAL fluid mitogenic activity for lung fibroblasts or alter the BAL fluid levels of the fibrogenic mediators transforming growth factor-ß1, platelet derived growth factor-AB, and thrombin.

Conclusions: A 3 day course of dexamethasone treatment initiated 3 days after bleomycin induced lung injury reduces lung cell proliferation and collagen deposition by mechanisms other than through reduction of transforming growth factor-ß1, platelet derived growth factor-AB, and thrombin levels in BAL fluid. We propose that an early short course treatment with dexamethasone may be useful in inhibiting pulmonary fibrosis.

Full Text

The Full Text of this article is available as a PDF (216.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson I. Y., Young L., Bowden D. H. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol. 1988 Feb;130(2):377–383. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson W. R., Engel R. R. Cardiopulmonary sequelae of reparative stages of bronchopulmonary dysplasia. Arch Pathol Lab Med. 1983 Nov;107(11):603–608. [PubMed] [Google Scholar]
  3. Belperio John A., Dy Maria, Burdick Marie D., Xue Ying Y., Li Kewang, Elias Jack A., Keane Michael P. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2002 Oct;27(4):419–427. doi: 10.1165/rcmb.2002-0009OC. [DOI] [PubMed] [Google Scholar]
  4. Coker R. K., Laurent G. J. Anticytokine approaches in pulmonary fibrosis: bringing factors into focus. Thorax. 1997 Mar;52(3):294–296. doi: 10.1136/thx.52.3.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coker R. K., Laurent G. J., Shahzeidi S., Lympany P. A., du Bois R. M., Jeffery P. K., McAnulty R. J. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 1997 Mar;150(3):981–991. [PMC free article] [PubMed] [Google Scholar]
  6. Dik Willem A., Zimmermann Luc J. I., Naber Brigitta A., Janssen Daphne J., van Kaam Anton H. L. C., Versnel Marjan A. Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant. Pediatr Pulmonol. 2003 Jan;35(1):34–41. doi: 10.1002/ppul.10219. [DOI] [PubMed] [Google Scholar]
  7. Fine A., Goldstein R. H. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem. 1987 Mar 15;262(8):3897–3902. [PubMed] [Google Scholar]
  8. Garland J. S., Alex C. P., Pauly T. H., Whitehead V. L., Brand J., Winston J. F., Samuels D. P., McAuliffe T. L. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics. 1999 Jul;104(1 Pt 1):91–99. doi: 10.1542/peds.104.1.91. [DOI] [PubMed] [Google Scholar]
  9. Giri S. N., Hyde D. M., Hollinger M. A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax. 1993 Oct;48(10):959–966. doi: 10.1136/thx.48.10.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grunze M. F., Parkinson D., Sulavik S. B., Thrall R. S. Effect of corticosteroids on lung volume-pressure curves in bleomycin-induced lung injury in the rat. Exp Lung Res. 1988;14(2):183–195. doi: 10.3109/01902148809115123. [DOI] [PubMed] [Google Scholar]
  11. Hagimoto N., Kuwano K., Nomoto Y., Kunitake R., Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol. 1997 Jan;16(1):91–101. doi: 10.1165/ajrcmb.16.1.8998084. [DOI] [PubMed] [Google Scholar]
  12. Hernnäs J., Nettelbladt O., Bjermer L., Särnstrand B., Malmström A., Hällgren R. Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat. Eur Respir J. 1992 Apr;5(4):404–410. [PubMed] [Google Scholar]
  13. Hernández-Rodríguez N. A., Cambrey A. D., Harrison N. K., Chambers R. C., Gray A. J., Southcott A. M., duBois R. M., Black C. M., Scully M. F., McAnulty R. J. Role of thrombin in pulmonary fibrosis. Lancet. 1995 Oct 21;346(8982):1071–1073. doi: 10.1016/s0140-6736(95)91744-6. [DOI] [PubMed] [Google Scholar]
  14. Herrera Luis J., Fernando Hiran C., Perry Yaron, Gooding William E., Buenaventura Percival O., Christie Neil A., Luketich James D. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg. 2003 Apr;125(4):929–937. doi: 10.1067/mtc.2003.18. [DOI] [PubMed] [Google Scholar]
  15. Howell D. C., Goldsack N. R., Marshall R. P., McAnulty R. J., Starke R., Purdy G., Laurent G. J., Chambers R. C. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2001 Oct;159(4):1383–1395. doi: 10.1016/S0002-9440(10)62525-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoyt D. G., Lazo J. S. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 1988 Aug;246(2):765–771. [PubMed] [Google Scholar]
  17. Khalil N., Bereznay O., Sporn M., Greenberg A. H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med. 1989 Sep 1;170(3):727–737. doi: 10.1084/jem.170.3.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Khalil N., Whitman C., Zuo L., Danielpour D., Greenberg A. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest. 1993 Oct;92(4):1812–1818. doi: 10.1172/JCI116771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Koenig W. J., Cross C. E., Hesterberg T. W., Last J. A. The smoking gun. Mechanism of methylprednisolone prevention of bleomycin-induced pulmonary fibrosis. Chest. 1983 May;83(5 Suppl):5S–7S. doi: 10.1378/chest.83.5_supplement.5s-a. [DOI] [PubMed] [Google Scholar]
  20. Kolb M., Margetts P. J., Galt T., Sime P. J., Xing Z., Schmidt M., Gauldie J. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):770–777. doi: 10.1164/ajrccm.163.3.2006084. [DOI] [PubMed] [Google Scholar]
  21. Kuwano K., Hagimoto N., Tanaka T., Kawasaki M., Kunitake R., Miyazaki H., Kaneko Y., Matsuba T., Maeyama T., Hara N. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol. 2000 Feb;190(2):221–229. doi: 10.1002/(SICI)1096-9896(200002)190:2<221::AID-PATH495>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  22. Kähäri V. M., Häkkinen L., Westermarck J., Larjava H. Differential regulation of decorin and biglycan gene expression by dexamethasone and retinoic acid in cultured human skin fibroblasts. J Invest Dermatol. 1995 Apr;104(4):503–508. doi: 10.1111/1523-1747.ep12605969. [DOI] [PubMed] [Google Scholar]
  23. Laurent G. J., Cockerill P., McAnulty R. J., Hastings J. R. A simplified method for quantitation of the relative amounts of type I and type III collagen in small tissue samples. Anal Biochem. 1981 May 15;113(2):301–312. doi: 10.1016/0003-2697(81)90081-6. [DOI] [PubMed] [Google Scholar]
  24. Laurent G. J., McAnulty R. J. Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen. Am Rev Respir Dis. 1983 Jul;128(1):82–88. doi: 10.1164/arrd.1983.128.1.82. [DOI] [PubMed] [Google Scholar]
  25. Lazenby A. J., Crouch E. C., McDonald J. A., Kuhn C., 3rd Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis. 1990 Jul;142(1):206–214. doi: 10.1164/ajrccm/142.1.206. [DOI] [PubMed] [Google Scholar]
  26. Lottenberg R., Christensen U., Jackson C. M., Coleman P. L. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol. 1981;80(Pt 100):341–361. doi: 10.1016/s0076-6879(81)80030-4. [DOI] [PubMed] [Google Scholar]
  27. Maeda A., Hiyama K., Yamakido H., Ishioka S., Yamakido M. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest. 1996 Mar;109(3):780–786. doi: 10.1378/chest.109.3.780. [DOI] [PubMed] [Google Scholar]
  28. Marshall R. P., Bellingan G., Webb S., Puddicombe A., Goldsack N., McAnulty R. J., Laurent G. J. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med. 2000 Nov;162(5):1783–1788. doi: 10.1164/ajrccm.162.5.2001061. [DOI] [PubMed] [Google Scholar]
  29. Marshall R., Bellingan G., Laurent G. The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax. 1998 Oct;53(10):815–817. doi: 10.1136/thx.53.10.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McAnulty R. J., Laurent G. J. Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol. 1995 Mar-Apr;3(2):96–107. [PubMed] [Google Scholar]
  31. Meduri G. U., Chinn A. J., Leeper K. V., Wunderink R. G., Tolley E., Winer-Muram H. T., Khare V., Eltorky M. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest. 1994 May;105(5):1516–1527. doi: 10.1378/chest.105.5.1516. [DOI] [PubMed] [Google Scholar]
  32. Meduri G. U., Tolley E. A., Chinn A., Stentz F., Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1432–1441. doi: 10.1164/ajrccm.158.5.9801107. [DOI] [PubMed] [Google Scholar]
  33. Mutsaers S. E., Bishop J. E., McGrouther G., Laurent G. J. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol. 1997 Jan;29(1):5–17. doi: 10.1016/s1357-2725(96)00115-x. [DOI] [PubMed] [Google Scholar]
  34. Mutsaers S. E., Foster M. L., Chambers R. C., Laurent G. J., McAnulty R. J. Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats. Am J Respir Cell Mol Biol. 1998 May;18(5):611–619. doi: 10.1165/ajrcmb.18.5.2898. [DOI] [PubMed] [Google Scholar]
  35. Oliver M. H., Harrison N. K., Bishop J. E., Cole P. J., Laurent G. J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci. 1989 Mar;92(Pt 3):513–518. doi: 10.1242/jcs.92.3.513. [DOI] [PubMed] [Google Scholar]
  36. Phan S. H., Thrall R. S., Williams C. Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism. Am Rev Respir Dis. 1981 Oct;124(4):428–434. doi: 10.1164/arrd.1981.124.4.428. [DOI] [PubMed] [Google Scholar]
  37. Sanders R. J., Cox C., Phelps D. L., Sinkin R. A. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994 Jul;36(1 Pt 1):122–128. doi: 10.1203/00006450-199407001-00022. [DOI] [PubMed] [Google Scholar]
  38. Santana A., Saxena B., Noble N. A., Gold L. I., Marshall B. C. Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1995 Jul;13(1):34–44. doi: 10.1165/ajrcmb.13.1.7541221. [DOI] [PubMed] [Google Scholar]
  39. Shull S., Meisler N., Absher M., Phan S., Cutroneo K. Glucocorticoid-induced down regulation of transforming growth factor-beta 1 in adult rat lung fibroblasts. Lung. 1995;173(2):71–78. doi: 10.1007/BF02981467. [DOI] [PubMed] [Google Scholar]
  40. Sterling K. M., Jr, Harris M. J., Mitchell J. J., DiPetrillo T. A., Delaney G. L., Cutroneo K. R. Dexamethasone decreases the amounts of type I procollagen mRNAs in vivo and in fibroblast cell cultures. J Biol Chem. 1983 Jun 25;258(12):7644–7647. [PubMed] [Google Scholar]
  41. Tani K., Yasuoka S., Ogushi F., Asada K., Fujisawa K., Ozaki T., Sano N., Ogura T. Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991 Jul;5(1):34–40. doi: 10.1165/ajrcmb/5.1.34. [DOI] [PubMed] [Google Scholar]
  42. Walsh J., Absher M., Kelley J. Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am J Respir Cell Mol Biol. 1993 Dec;9(6):637–644. doi: 10.1165/ajrcmb/9.6.637. [DOI] [PubMed] [Google Scholar]
  43. Wang Q., Wang Y., Hyde D. M., Gotwals P. J., Koteliansky V. E., Ryan S. T., Giri S. N. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax. 1999 Sep;54(9):805–812. doi: 10.1136/thx.54.9.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yi E. S., Salgado M., Williams S., Kim S. J., Masliah E., Yin S., Ulich T. R. Keratinocyte growth factor decreases pulmonary edema, transforming growth factor-beta and platelet-derived growth factor-BB expression, and alveolar type II cell loss in bleomycin-induced lung injury. Inflammation. 1998 Jun;22(3):315–325. doi: 10.1023/a:1022304317111. [DOI] [PubMed] [Google Scholar]
  45. Yoshida M., Sakuma-Mochizuki J., Abe K., Arai T., Mori M., Goya S., Matsuoka H., Hayashi S., Kaneda Y., Kishimoto T. In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis. Biochem Biophys Res Commun. 1999 Nov 19;265(2):503–508. doi: 10.1006/bbrc.1999.1647. [DOI] [PubMed] [Google Scholar]
  46. Zhu Z., Lee C. G., Zheng T., Chupp G., Wang J., Homer R. J., Noble P. W., Hamid Q., Elias J. A. Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S67–S70. doi: 10.1164/ajrccm.164.supplement_2.2106070. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES